Gullapalli will oversee the Amgen India Technology and Innovation hub, leveraging his extensive expertise in global ...

Amgen appointed Naveen Gullapalli, former Novartis executive, as Managing Director of Amgen India. Gullapalli will lead Amgen ...

Amgen appoints Naveen Gullapalli as managing director to accelerate tech & innovation from India: Our Bureau, Bengaluru ...

Naveen Gullapalli has been appointed as Managing Director of Amgen's India Technology and Innovation Hub in Hyderabad, ...

An Amgen manufacturing facility in Thousand Oaks ... bringing more industry into the whole county.” Enjoy Triangle tech news? Subscribe to Open Source, The News & Observer's weekly newsletter ...

In November 2024, investors received sobering news about Amgen's obesity ambitions, a key driver of the biotech stock's strong performance earlier in the year. Specifically, the company's mid ...

A higher risk of infections was observed in the BLINCYTO arm. For More Such Health News, visit rttnews.com. Amgen NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best affordable stocks to buy. There has been a growing debate regarding whether the economy of ...

(RTTNews) - Amgen, Inc. (AMGN) announced Thursday a $1 billion expansion to establish a second drug substance manufacturing facility in North Carolina. This brings the company's total planned ...

Amgen, headquartered in California, is a publicly traded company and one of 30 in the Dow Jones Industrial, according to a state news release. It has more than 27,000 employees globally.

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions.